# Hyperfine, Inc. (HYPR)

> Source: Nexqual · https://nexqual.com/HYPR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Hyperfine, Inc. (HYPR), nexqual.com/HYPR" · informational, not investment advice.

**Price:** USD 0.78 (-2.50% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.8 · day 0.76–0.81 · 52w 0.75–1.94 · market cap $82.7M · NGM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 2.03 (range 1.6–2.5).
- Total return with dividends: 1Y -45.1% vs S&P 500 +18.1%; 5Y -92.2% vs S&P 500 +85.1%.
- Next earnings: 2026-11-09, EPS estimate USD -0.08, revenue estimate $5.8M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 2.03 (low 1.6, high 2.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-22 | BTIG | Reiterated | Buy | $2 |
| 2026-09-14 | BTIG | Reiterated | Buy | $2 |
| 2026-08-10 | B. Riley Securities | Target lowered | Buy | $2 → $1.6 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -45.1% | -92.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -45.2% | -39.8% |
| Volatility (annualized) | 70.4% | 85.5% |
| Max drawdown | -58.7% (May 2026→Sep 2026) | -94.5% (Oct 2021→May 2025) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/HYPR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt